Radiotherapy Market Growth Analysis and Forecast 2017-2024: Varian Medical Systems, Elekta AB, Accuray, CIVCO Medical Solutions and Brainlab AG
Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.To request a free sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiotherapy-market
Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumors that cause metastasis. In current healthcare scenario localized treatment of tumors the only efficient treatment for tumors. Radiosurgery is used alongside surgery or separately to treat cancer for a long time. More than 75% of the cancer patient population is expected to take radiosurgery in some point of their disease prognosis.
To Know More About Report Visit @ https://youtu.be/LK0mFjSWvGE
There has been rapid development in the radiosurgery field in recent years, owing to increased threat of multiple cancers and mortality. This has allowed pulling in large government and healthcare manufacturers funding’s in research labs developing treatment and preventive techniques against cancer. The Elekta gamma knife has completed more than 1 million surgeries as announced by Elekta in May 2016. This shows the demand of radiotherapy products, and the requirement of disruptive technologies to change to modern day radiotherapy. According to Hospital Cost and Utilization Project (HCUP) the number of radiotherapy procedures is increasing in U.S. by 2.0% every year.
China is expected to continue its impressive growth in radiotherapy equipments along with high growth in India, Brazil, Russia and other emerging economies. The developed countries such as Germany, France, U.S., U.K., Japan among others is expected to be boosted owing to government funding and increasing awareness of systemic radiotherapy and other developed radiotherapy treatments.
Have Any Query? Inquire here @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiotherapy-market
The global radiotherapy market is segmented based on therapy, product, application and geography. Based on the therapy, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy. On the basis of radiations delivered, the external beam radiotherapy is sub segmented into intensity-modulated radiation therapy (IMRT), image guided radiotherapy (IGRT), tomotherapy, stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and volumetric modulated arc therapy (VMAT).
The IGRT segment is expected to account for the largest share of the external beam radiotherapy market, whereas the VMAT segment is poised to witness the highest growth. Based on the delivery of dose-rate, the internal beam therapy is divided into low (LDR) and high-dose rate (HDR). The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.
Based on product type the global radiotherapy market is segmented into EBRT equipment’s, and IBRT equipment’s. The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron). The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.
The global radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.
Questions? We’ll Put You On The Right Path Request Analyst Call @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-radiotherapy-market
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world.
North America is expected to dominate the market with 46.2% in 2017 in terms of market value. However the APAC region is expected to grow at the highest CAGR in the forecast period 2017 to 2024.The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
Global Radiotherapy Market globally Varian Medical Systems, Inc. dominated the radiotherapy market accounting for a market share in 2016. The market is highly fragmented based on technologies offered by different manufacturers are different. The major players are concentrating on product development and strategic mergers with healthcare payers and providers to penetrate the market.
Read more about the Global Radiotherapy Market Landscape: http://databridgemarketresearch.com/reports/global-radiotherapy-market/
TABLE OF CONTENTS GLOBAL RADIOTHERAPY MARKET
1. INTRODUCTION
1.1. OVERVIEW OF GLOBAL RADIOTHERAPY MARKET
1.1.1. CURRENCY AND PRICING
1.1.2. LIMITATION
1.1.3. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. GROWING PREVALENCE OF CANCER
3.1.2. RISING AGEING POPULATION
3.1.3. UNHEALTHY LIFESTYLE
3.1.4. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO
3.2.2. HIGH COST OF RADIOTHERAPY
3.3. OPPORTUNITIES
3.3.1. GROWING MEDICAL TOURISM IN ASIA
3.3.2. EMERGING MARKET
3.4. CHALLENGES
3.4.1. SIDE-EFFECTS OF RADIOTHERAPY
3.4.2. REQUIREMENT OF TRAINED STAFF
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL RADIOTHERAPY MARKET, BY THERAPY TYPE
6.1. OVERVIEW
6.2. BEAM RADIOTHERAPY, BY THERAPY TYPE
6.3. BRACHYTHERAPY, BY THERAPY TYPE
7. GLOBAL RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.1. OVERVIEW
7.2. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.3. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.4. GLOBAL RADIOTHERAPY SOFTWARES MARKET, BY PRODUCT TYPE
8. GLOBAL RADIOTHERAPY MARKET, BY INDICATION
8.1. OVERVIEW
9. GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.2. NORTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016
9.2.1. U.S. RADIOTHERAPY MARKET
9.2.2. CANADA RADIOTHERAPY MARKET
9.2.3. MEXICO RADIOTHERAPY MARKET
9.3. EUROPE RADIOTHERAPY MARKET
9.3.1. GERMANY RADIOTHERAPY MARKET
9.3.2. FRANCE RADIOTHERAPY MARKET
9.3.3. U.K. RADIOTHERAPY MARKET
9.3.4. SWITZERLAND RADIOTHERAPY MARKET
9.3.5. ITALY RADIOTHERAPY MARKET
9.3.6. RUSSIA RADIOTHERAPY MARKET
9.3.7. NETHERLANDS RADIOTHERAPY MARKET
9.3.8. SPAIN RADIOTHERAPY MARKET
9.3.9. BELGIUM RADIOTHERAPY MARKET
9.3.10. TURKEY RADIOTHERAPY MARKET
9.4. APAC RADIOTHERAPY MARKET SNAPSHOT: 2016
9.4.1. JAPAN RADIOTHERAPY MARKET
9.4.2. CHINA RADIOTHERAPY MARKET
9.4.3. INDIA RADIOTHERAPY MARKET
9.4.4. SOUTH KOREA RADIOTHERAPY MARKET
9.4.5. AUSTRALIA RADIOTHERAPY MARKET
9.4.6. THAILAND RADIOTHERAPY MARKET
9.4.7. MALAYSIA RADIOTHERAPY MARKET
9.4.8. INDONESIA RADIOTHERAPY MARKET
9.4.9. SINGAPORERADIOTHERAPY MARKET
9.4.10. PHILIPPINES RADIOTHERAPY MARKET
9.5. SOUTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016
9.5.1. BRAZIL RADIOTHERAPY MARKET
9.6. MEA RADIOTHERAPY MARKET SNAPSHOT: 2016
9.6.1. SAUDI ARABIA RADIOTHERAPY MARKET
10. GLOBAL RADIOTHERAPY MARKET, COMPANY SHARE
10.1. COMPANY SHARE ANALYSIS: GLOBAL
10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3. COMPANY SHARE ANALYSIS: EUROPE
10.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
11. COMPANY PROFILES
11.1. VARIAN MEDICAL SYSTEMS, INC.
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.1.3. DRIVERS EXPLAINED
11.1.3.1. DIVERSE PRODUCT PORTFOLIO:
11.1.3.2. STRONG RESEARCH AND DEVELOPMENT CAPABILITIES:
11.1.4. WEAKNESSES EXPLAINED
11.1.4.1. DEPENDENCE ON LIMITED NUMBER OF SUPPLIERS:
11.1.5. OPPURTUNITIES EXPLAINED
11.1.5.1. VARIAN COULD EXPAND ITS POSITION WITH IMAGING COMPONENTS BUSINESS’ SPIN-OFF:
11.1.5.2. ACQUISITIONS LIKELY TO ENHANCE VARIAN’S ONCOLOGY AND IMAGING BUSINESSES:
11.1.5.3. EXPANSION IN OPERATIONS IN THE U.S.:
11.1.5.4. INCREASING INCIDENCE OF CANCER TO DRIVE GLOBAL RADIATION THERAPY EQUIPMENT MARKET:
11.1.6. THREATS EXPLAINED
11.1.6.1. INTENSE COMPETITION COULD AFFECT VARIAN’S MARKET SHARE AND RESULTS OF OPERATION:
11.1.6.2. INCREASING MEDICAL COSTS IN CANCER TREATMENT AND CARE: 259
11.1.7. REVENUE ANALYSIS
11.1.8. PRODUCT PORTFOLIO
11.1.9. RECENT DEVELOPMENTS
11.1.10. DATA BRIDGE ANALYSIS
11.2. ELEKTA AB
11.2.1. COMPANY OVERVIEW
11.2.2. REVENUE ANALYSIS
11.2.3. PRODUCT PORTFOLIO
11.2.4. RECENT DEVELOPMENTS
11.2.5. DATA BRIDGE ANALYSIS
11.3. NANOBIOTIX
11.3.1. COMPANY OVERVIEW
11.3.2. REVENUE ANALYSIS
11.3.3. PRODUCT PORTFOLIO
11.3.4. RECENT DEVELOPMENTS
11.3.5. DATA BRIDGE ANALYSIS
11.4. ACCURAY, INC.
11.4.1. COMPANY OVERVIEW
11.4.2. REVENUE ANALYSIS
11.4.3. PRODUCT PORTFOLIO
11.4.4. RECENT DEVELOPMENTS
11.5. BRAINLAB AG
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.5.3. DRIVERS EXPLAINED
11.5.3.1. STRONG PARTNER NETWORK:
11.5.3.2. ESTABLISHED PRESENCE IN MARKETS:
11.5.4. WEAKNESSES EXPLAINED
11.5.4.1. PRODUCT SAFETY CONCERNS:
11.5.5. OPPURTUNITIES EXPLAINED
11.5.5.1. STRATEGIC INITIATIVES:
11.5.6. THREATS EXPLAINED
11.5.6.1. RAPID TECHNOLOGICAL CHANGES:
11.5.6.2. STRINGENT GOVERNMENT REGULATIONS:
11.5.7. REVENUE ANALYSIS
11.5.8. PRODUCT PORTFOLIO
11.5.9. RECENT DEVELOPMENTS
11.6. ION BEAM APPLICATIONS SA
11.6.1. COMPANY OVERVIEW
11.6.2. REVENUE ANALYSIS
11.6.3. PRODUCT PORTFOLIO
11.6.4. RECENT DEVELOPMENTS
11.7. MEVION MEDICAL SYSTEMS, INC.
11.7.1. COMPANY OVERVIEW
11.7.2. REVENUE ANALYSIS
11.7.3. PRODUCT PORTFOLIO
11.7.4. RECENT DEVELOPMENTS
11.8. ISORAY MEDICAL, INC.
11.8.1. COMPANY OVERVIEW
11.8.2. REVENUE ANALYSIS
11.8.3. PRODUCT PORTFOLIO
11.8.4. RECENT DEVELOPMENTS
11.9. NORDION (CANADA) INC.
11.9.1. COMPANY OVERVIEW
11.9.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
11.9.3. DRIVERS EXPLAINED
11.9.3.1. ESTABLISHED PRESENCE IN GAMMA IRRADIATION INDUSTRY:
11.9.4. WEAKNESSES EXPLAINED
11.9.4.1. RADIATION EXPOSURE CLAIMS AND OTHER DISPUTES:
11.9.5. OPPURTUNITIES EXPLAINED
11.9.5.1. STRATEGIC INITIATIVES:
11.9.6. THREATS EXPLAINED
11.9.6.1. RAPID TECHNOLOGICAL CHANGES:
11.9.6.2. STRINGENT GOVERNMENT REGULATIONS:
11.9.6.3. STIFF COMPETITION:
11.9.7. REVENUE ANALYSIS
11.9.8. PRODUCT PORTFOLIO
11.9.9. RECENT DEVELOPMENTS
11.10. RAYSEARCH LABORATORIES AB
11.10.1. COMPANY OVERVIEW
11.10.2. REVENUE ANALYSIS
11.10.3. PRODUCT PORTFOLIO
11.10.4. RECENT DEVELOPMENTS
11.11. PRECISIS AG
11.11.1. COMPANY OVERVIEW
11.11.2. REVENUE ANALYSIS
11.11.3. PRODUCT PORTFOLIO
11.11.4. RECENT DEVELOPMENTS
12. RELATED REPORTS
Related Report
Europe Radiotherapy Market – Industry Trends and Forecast to 2024
Europe Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/europe-radiotherapy-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiotherapy Market Growth Analysis and Forecast 2017-2024: Varian Medical Systems, Elekta AB, Accuray, CIVCO Medical Solutions and Brainlab AG here
News-ID: 1049269 • Views: …
More Releases from Data Bridge Market Research
Analysis of Industry Trends and Forecast for the Global Market of Consumer Devic …
"In the reliable Intelligent Assistant Embedded Consumer Devices Market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Intelligent Assistant Embedded Consumer Devices Market industry. A team of innovative analysts, research experts, statisticians, forecasters and economists work strictly to present with the advanced and all-inclusive market research report. This market report also covers strategic profiling of major…
Analysis of Industry Trends and Projected Growth in the Global Market for Implan …
"Implantable Pulse Generators Market research report explores the key parameters for Implantable Pulse Generators Market industry namely market analysis, market definition, market segmentation, key developments in the market, competitive analysis, and research methodology. This world class report gives estimations of Compound Annual Growth Rate (CAGR) in % value for the forecasted period that will assist client to take decision based on futuristic chart. The report defines CAGR value fluctuations during the…
Analysis of Industry Trends and Forecast for the Global Impact Resistant Glass M …
"While crafting Impact Resistant Glass Market research report, marketing administration is extremely aware about certain things that include the minds of target markets, feelings, preferences, attitudes, convictions and value systems. A formalised and managerial approach has been taken up to do the same to understand all the above mentioned aspects. This market report also provides the complete overview of the market, covering various aspects such as product definition, market segmentation,…
Industry Trends and Projected Growth in the Global Market for Hodgkin Lymphoma D …
"While crafting Hodgkin Lymphoma Drug Market research report, marketing administration is extremely aware about certain things that include the minds of target markets, feelings, preferences, attitudes, convictions and value systems. A formalised and managerial approach has been taken up to do the same to understand all the above mentioned aspects. This market report also provides the complete overview of the market, covering various aspects such as product definition, market segmentation,…
More Releases for THERAPY
Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023.
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand…
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market.
Factors that are likely to hamper the growth of the market…